Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Could stand with calipers and walker (after 7...

By: neurogenbsi

Read this article:
Stem Cell Therapy Treatment for Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. - Video

Stem Cell Therapy Treatment Improvements in Muscular Dystrophy by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment Improvements in Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Could stand with calipers and wal...

By: neurogenbsi

Follow this link:
Stem Cell Therapy Treatment Improvements in Muscular Dystrophy by Dr Alok Sharma, Mumbai, India. - Video

Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy 1. Ankle clonus/jerk in both legs has reduced. P...

By: neurogenbsi

Link:
Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma, Mumbai, India. - Video

Stem Cell Therapy Treatment for Cerebral Palsy by Dr Alok Sharma, Mumbai, India.
Stem Cell Therapy Treatment for Cerebral Palsy by Dr Alok Sharma, Mumbai, India. After Stem Cell Therapy PT assessment: 1) Speech has improved. Now he is abl...

By: neurogenbsi

See original here:
Stem Cell Therapy Treatment for Cerebral Palsy by Dr Alok Sharma, Mumbai, India. - Video

ARAD, Israel, April 2, 2013 /PRNewswire/ --

Andain Inc. (ANDN) ("Andain" or the "Company"), a company engaged in commercializing novel technologies in biotech, medical and life sciences fields through its incubator program, today discussed and provided an update on its breakthrough, innovative stem cell therapy for treating and regenerating severely damaged muscle tissue.

Andain's innovative stem cell therapy technology rehabilitates and heals damaged muscle tissue by initiating regenerative myogenic cells (cardiac muscle), as well as striated muscle cells (skeletal muscle) growth in damaged tissue sites such as the myocardium (cardiac muscle) following an myocardial infarction (heart attack), limb pressure ulcers, and degenerative muscular diseases. The short term application is directed towards the treatment of patients with peripheral vascular disease, while the long term application is focused on the healing and regeneration of cardiac muscle following acute myocardial infarction or chronic heart failure.

Employing a patient's own cells (autologic transplantation), the Company's unique technology and process diverts the patient's own cells into specific targeted myogenic cells, which can then be inserted into the damaged tissue and accelerates the healing process. The administered myogenic or skeletal stem cells work as a network, acting in exactly the same way that the cells of skeletal and heart muscle tissue perform, and actually replenish the existing cells, thus strengthening the intended injured site following the transplantation process. This process can be utilized for different clinical pathologies as mentioned above and can also be utilized for patient using different donor as the source of the stem cells.

Our developed technology and protocols results in a promising safe regenerative therapy, without side effects, tissue rejection or the requirement of suppressive immunological treatment or malignant tumor hazard. Our technology also provides a simple, fast and safe treatment, overcoming technological difficulties associated with using other stem cell therapies sources such as embryonic, placenta, or umbilical cord blood cells that require cryogenic storage.

Andain's President and CEO Sam Elimelech, commented, "The field of stem cell therapeutics is in its early stages of growth as companies and researchers continue to uncover the vast potential and promising uses for them in the treatment and prevention of countless tissue injuries and diseases. We are in an excellent position to capitalize on the emergence of this new market. It is our belief that Orcell's cutting-edge technology and process is unique in regard to the fact that it allows for the safe and efficient directing of the patients own cells as into myogenic cells or striated muscle cells, thus eliminating the hazards associated with rejection and malignant tumors. Via our industrial incubator platform and expert scientific team, we look forward to helping Orcell commence their clinical trials later this year and make considerable progress of their technology and process closer to market."

Andain's incubator platform is currently undergoing with its stem cell technology a build-up of GLP (Good Laboratory Practice) production line as a preparation for the FDA approval stage with clinical trials scheduled for Q1 2014 at one of the foremost Heart centers in Israel under the direction of Professor Mickey Scheinowitz, one of Israel's leading scientists who gained vast experience in the understanding and treating of cardiovascular diseases.

ABOUT ANDAIN INC

Established in 2004 as a Nevada corporation with locations in Israel and the US, Andain (OTC: ANDN) commercializes novel technologies in the biotech, medical and life sciences fields, specializing in identifying technical innovations and providing a unique incubator/accelerator development and industrial platform. The company also offers technical know-how and business strategy expertise to commercialize new technologies and deliver shareholder value. For more information, please visit our website at http://www.andaininc.com.

FORWARD LOOKING STATEMENTS

Here is the original post:
Andain Inc. Discusses and Provides Update on its Breakthrough Stem Cell Therapy for the Treatment and Regeneration of ...

By Tina G. Santos Philippine Daily Inquirer

MANILA, PhilippinesStem cell therapy at spa centers and salons? Watch out, government agents are coming.

Health Secretary Enrique Ona says no clinic or hospital in the Philippines can offer stem cell therapy without accreditation from the Department of Health (DOH).

Speaking to reporters last week, Ona noted that while many centers are advertising stem cell therapy treatment, none of them have the approval of the health department.

As of now we have not accredited any clinic or even hospital offering stem cell therapy yet, Ona said.

Admitting that the DOH doesnt have the police power to close down erring health centers, Ona said the department would coordinate with other governmental agencies like the Department of Trade and Industry (DTI) and local governments to prevent spas and salons from offering stem cell treatment.

We will issue a warning for them to stop [doing stem cell therapy]. But if they continue despite warnings from us, thats when we will move to close them down, Ona said.

Stem cell therapy and treatment, which are becoming popular here and abroad, are medical procedures that deal with ailments by replacing malignant cells with healthy cells.

Only medical doctors with the right training can perform stem cell treatment.

Cosmetic purposes

Read the original post:
Spas, salons warned on stem cell therapy

USU hosting 13th annual Biotechnology Summer Academy Cache Valley Daily Utah State University is again offering summer laboratory experiences for high school students interested in biological sciences and engineering. The 13th annual Biotechnology Summer Academy will be held July 8-12. Summer Academy is a one-week ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHREnjtMJpvX7MmmrB7kGkDmvCAnw&url=http://www.cachevalleydaily.com/news/local/article_47766e14-98f7-11e2-9e63-0019bb30f31a.html

How to Talk About Biotechnology Discover Magazine (blog) It's been said before, but it bears repeating that genetic modification is little more than a new tool in the perennial human endeavor to modify the biology that surrounds us – a project that exploded with the advent of agriculture and the development ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGn8QmKgF3G-IK6hjNxf0sw0fzOrg&url=http://blogs.discovermagazine.com/collideascape/?p%3D10881

THISDAY Live

Sign Agric Biotechnology Bill into Law, Saraki Appeals to Jonathan THISDAY Live Former governor of Kwara State, Senator Bukola Saraki, Wednesday urged President Goodluck Jonathan, to as a matter of urgency, assent to Agricultural Biotechnology Bill earlier passed by the two chambers of the National Assembly. Saraki, who represents ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNH8ym5Eb9PLkNYWZkYiEhHj_-OVdw&url=http://www.thisdaylive.com/articles/sign-agric-biotechnology-bill-into-law-saraki-appeals-to-jonathan/143411/

Evening Observer

SUNY Fredonia's Ferguson earns National Science Foundation grant Evening Observer Though not funded by the $250,000 National Science Foundation grant he just received, it will be a key instrument in his molecular genetics research. Ferguson, who earned a doctorate in genetics and gene regulation from the University of Pennsylvania ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNEBQHNyS-H-22ATTLL3hEFjQSI1MQ&url=http://www.observertoday.com/page/content.detail/id/583008/SUNY-Fredonia-s-Ferguson-earns-National-Science-Foundation-grant.html?nav%3D5053

Edison inks pact with Japanese-based DSP for developing orphan mitochondrial ... pharmabiz.com The positive clinical results of a phase II A trial of EPI - 743 in children with Leigh syndrome were recently reported in Molecular Genetics and Metabolism (EPI - 743 reverses the progression of the paediatric mitochondrial disease — Genetically ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNGtpOeKWayL2OgVLR6QcPVbthK2qg&url=http://www.pharmabiz.com/NewsDetails.aspx?aid%3D74525%26sid%3D2

LA Weekly (blog)

Scientists Use DNA to Determine Food Contents LA Weekly (blog) Scientists at the Institute of Molecular Genetics, Genetic Security Research and Consulting at Johannes Gutenberg University in Mainz have adapted the latest techniques of DNA sequencing, which are otherwise employed in human genetics, and applied ...

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNF4vg22sIGvi9SwirIRxtMFCM_Q0A&url=http://blogs.laweekly.com/squidink/2013/03/scientists_use_dna_to_determin.php

New York Daily News

DNA Testing For Cancer 'Routine Within Five Years'29 Huffington Post UK Their findings appear in 13 papers in five journals, Nature Genetics, Nature Communications, PLoS Genetics, the American Journal of Human Genetics and Human Molecular Genetics. The chip used in the analysis cost just £30, and although the study relied ... Record gene haul points to better cancer screeningTimes LIVE Study gives new insight into genetic risk of breast, prostate and ovarian cancersWellcome Trust 74 genetic errors identified as markers for increased cancer riskCBS News University of Manchester -ScienceAlert -Medscape all 130 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNHBrgMIZ5Dy4Sb3sbGCajzl7g0jGQ&url=http://www.huffingtonpost.co.uk/2013/03/27/dna-testing-for-cancer_n_2965388.html?ir%3DUK%2BLifestyle

A post entitled Funding for Personalized Medicine Research, dated January 31, 2012, provided information about the participation of the Cancer Stem Cell Consortium (CSCC) in the Large-Scale Applied Research Project Competition of Genome Canada, in collaboration with the first phase of the Personalized Medicine Signature Initiative of the Canadian Institutes of Health Research (CIHR).

On March 26, 2013, it was announced that 17 projects will be supported. A list of these project is available (PDF). One of the 17 projects is entitled "Innovative chemogenomic tools to improve outcome in acute myeloid leukemia". The Project leader is Guy Sauvageau of the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal. The Project co-leader is Josée Hébert of the Centre de Recherche Hôpital Maisonneuve-Rosemont, Montréal. One of the aims of this project is to develop new models for tracking cancer stem cells that are left behind after a patient is treated.

Source:
http://cancerstemcellnews.blogspot.com/2013/03/more-about-funding-for-personalized.html

The Malaysian Insider

Scientists Identify Genetic Causes For Prostate, Breast And Ovarian Cancer In ... South Asia Mail COGS has released a batch of 13 papers in five journals this week, including: Nature Communications, Nature Genetics, PLOS Genetics, the American Journal of Human Genetic, and Human Molecular Genetics. The study will lead to a deeper understanding ... Scientists pinpoint gene coding errors for cancerThe Malaysian Insider all 6 news articles »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNFyRcaPUuO-O8gdyWSTMFH7PrQqEQ&url=http://www.southasiamail.com/news.php?id%3D109674

Science journalist Emily Anthes explores biotech's innovations in a new book CNN - Canada The techniques of molecular genetics really lets us go in and, for the first time, target very specific individual genes. One of the big areas of interest has been in creating hypoallergenic pets. With cats, for instance, there's one gene in particular ... and more »

Source:
http://news.google.com/news/url?sa=t&fd=R&usg=AFQjCNE5cuQjoegaBm32lK6cE8n8nbfBOg&url=http://www.cnn.com/2013/03/29/tech/innovation/biotech-animals-emily-anthes/

Italian health officials are allowing a handful of patients to continue with a controversial stem cell therapy amid protests from scientists that the treatments are unproven and unsafe.

The Stamina Foundation has been administering the therapy at the public hospital Spedali Civili of Brescia to people with a range of degenerative diseases. Their approach is based on mesenchymal stem cells, derived from bone marrow, which can become mature bone and connective tissue.

In 2011 the hospital agreed to host the research and assist with cell extraction and patient treatments, stirring protests from the medical community. "The hospital is not even listed among the 13 Italian authorised stem cell factories," says Michele de Luca, director and gene therapy programme coordinator at the Centre for Regenerative Medicine in Modena. After an inspection in 2012, Italian drug regulator AIFA ordered an immediate halt to Stamina's stem cell treatments at the hospital.

The AIFA report says the Stamina Foundation's treatment did not follow Italy's official path required for clinical approval. So far no scientific publications describing its effectiveness are available.

But the halt sparked protests among patients' families who believed the treatment was working. Some appealed to the courts, and as a result a few patients were allowed to go ahead with the therapy. On 15 March, a group of 13 Italian stem cell researchers published an open letter to the country's Minister of Health, Renato Balduzzi, asking him to shut down all of the Stamina Foundation's treatments at the hospital.

Instead Balduzzi signed a bill last week authorising the foundation to continue treatments in patients who had already begun the regime unless they are experiencing serious side effects.

If you would like to reuse any content from New Scientist, either in print or online, please contact the syndication department first for permission. New Scientist does not own rights to photos, but there are a variety of licensing options available for use of articles and graphics we own the copyright to.

Only subscribers may leave comments on this article. Please log in.

Only personal subscribers may leave comments on this article

Subscribe now to comment.

Visit link:
Italy pushes on with controversial stem cell therapy

Albany, NY (PRWEB) March 29, 2013

GBI Research, the leading business intelligence provider, has released its latest research Stem Cell Therapy Market in Asia-Pacific to 2018 Commercialization Supported by Favorable Government Policies, Strong Pipeline and Increased Licensing Activity. The report provides an in-depth analysis on stem cell research and development in India, China, Japan, South-Korea and Singapore. The report market analysis and forecasts for CABG, LSCT, Type 1 DM, Type 2 DM, Hearticellgram, Cerecellgram, Cartistem and Cupistem. The report also provides information on trends and pipelines. In addition to this, the report covers market drivers and challenges for stem cell research market.

To Read the Complete Report with TOC Visit: http://www.marketresearchreports.biz/analysis/155690

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GBI Researchs team of industry experts.

GBI Research analysis finds the stem cell therapy market was valued at $545m in 2012, and is projected to grow at a Compound Annual Growth Rate (CAGR) of 10% from 2012 to 2018, to attain a value of $972m in 2018. The market is poised for significant growth in the forecast period due to the anticipated launch of JCR Pharmaceuticals JR-031 (2014) in Japan and FCB Pharmicells Cerecellgram (CCG) (2015) in South Korea.

Related Report: Mobile Health (mHealth) - Enhancing Healthcare and Improving Clinical Outcomes

The research is mainly in early stages, with the majority of the molecules being in early stages of development (Phase I/II and Phase II). Phase I/II and Phase II contribute 67% of the pipeline. Stem cell research is dominated by hospitals/universities/institutions, which contribute 63% of the molecules in the pipeline. The dominance of institutional research is attributable to uncertain therapeutic outcomes in stem cell research.The major companies conducting research in India include Reliance Life Sciences and Stempeutics Research Pvt Ltd, among others. The major institutions include PGIMER and AIIMS.

Latest Report: Global SMB Web Analytics Market 2012-2016

Scope

Healthcare Report: Generic Growth Strategies - Market Driven by Impending Patent Cliff, Declining R&D Productivity and Government Initiatives to Reduce Healthcare Costs

Originally posted here:
Stem Cell Therapy Market in Asia-Pacific to 2018 Market Research Report Available at MarketResearchReports.biz

Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma
Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma After Stem Cell Therapy 1) Ankle dorsiflexion movements are possible now. 2) He is able ...

By: neurogenbsi

More here:
Stem Cell Therapy Treatment for Spinal Cord Injury by Dr Alok Sharma - Video

Stem Cell Therapy Treatment for Autism by Dr Alok Sharma
Stem Cell Therapy Treatment for Autism by Dr Alok Sharma After Stem Cell Therapy 1) Eye contact improved (not very marked). 2) Increased interaction with sis...

By: neurogenbsi

Follow this link:
Stem Cell Therapy Treatment for Autism by Dr Alok Sharma - Video